Clinical Trial Update: Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

View source ↗

Summary

A long-term follow-up study of AL-001 ophthalmic injection for wet age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• AL-001 Ophthalmic Injection (AL-001)

Snippet

Sponsor: Beijing Anlong Biopharmaceutical Co., Ltd. | Conditions: Wet Age-related Macular Degeneration (wAMD) | Status: RECRUITING